What is the relationship between adiponectin and insulin resistance?

Adiponectin and insulin resistance have a bidirectional inverse relationship. Low adiponectin reduces insulin sensitivity in muscle and liver, promoting insulin resistance. Insulin resistance, in turn, suppresses adiponectin secretion from fat cells through inflammatory pathways. This creates a self-reinforcing cycle where declining adiponectin worsens insulin resistance, which further suppresses adiponectin. Breaking this cycle requires addressing visceral adiposity through diet, exercise, and metabolic intervention.

Lab Reference Library / Adiponectin Metabolic Health

Adiponectin

Q: How do you increase adiponectin naturally?

Evidence-based interventions to raise adiponectin include: weight loss (particularly reduction of visceral adipose tissue), regular aerobic exercise (the most potent single stimulus for adiponectin secretion), Mediterranean diet pattern, adequate omega-3 intake, magnesium supplementation, adequate sleep, reduction of fructose and refined carbohydrates, berberine, and in appropriate candidates, metformin. Reducing visceral fat is the most impactful intervention as visceral adipose tissue is the primary source of adiponectin suppression.

ADPN · Adipokine · GBP-28

Reference range, optimal functional medicine levels, and why adiponectin, the anti-inflammatory adipokine secreted by fat tissue, is paradoxically low in obesity and insulin resistance and serves as one of the most sensitive early markers of metabolic dysfunction.

Most SearchedMetabolic Marker

Standard Range (M)3 to 20 mcg/mL

FM Optimal (M)Above 10 mcg/mL

FM Optimal (W)Above 12 mcg/mL

Unitsmcg/mL

← Back to Lab Reference Library

Category: Metabolic Health | Also known as: ADPN, Adipokine, GBP-28 | Sample: Serum (fasting preferred for consistency)

1. What This Test Measures

Adiponectin is a peptide hormone secreted exclusively by adipocytes (fat cells), making it unique among metabolic hormones: it is the only major hormone produced entirely by fat tissue that has overwhelmingly beneficial metabolic effects. Adiponectin exists in three major structural forms in circulation: trimers (low molecular weight), hexamers (medium molecular weight), and high molecular weight (HMW) multimers. HMW adiponectin is the most biologically active fraction and the strongest predictor of insulin sensitivity and cardiovascular risk.

The paradox of adiponectin is fundamental to understanding metabolic disease: despite being produced by fat cells, adiponectin levels are inversely proportional to total body fat, and particularly to visceral fat. The more visceral adipose tissue a person accumulates, the less adiponectin their fat cells produce. This inverse relationship means that obesity is characterized by a deficiency of a critical anti-inflammatory, insulin-sensitizing hormone, creating a self-reinforcing cycle of metabolic deterioration.

Adiponectin exerts its effects through two primary receptors: AdipoR1 (expressed primarily in skeletal muscle) and AdipoR2 (expressed primarily in the liver). Through these receptors it activates AMPK and PPAR-alpha signaling pathways, the same pathways targeted by metformin and fibrate medications respectively.

2. Why This Test Matters

Early insulin resistance detection: adiponectin falls before fasting glucose, HbA1c, or even fasting insulin becomes significantly abnormal. It is one of the earliest detectable markers of metabolic dysfunction, identifying risk 10 to 15 years before type 2 diabetes diagnosis in prospective studies.
Complements fasting insulin: while fasting insulin detects compensatory hyperinsulinemia, adiponectin detects the adipose tissue dysfunction driving the entire metabolic cascade. Together, low adiponectin and elevated fasting insulin provide confirmation of insulin resistance from two independent biological mechanisms.
Independent cardiovascular risk marker: multiple large prospective studies (including the Health Professionals Follow-up Study and the Nurses Health Study) demonstrate that low adiponectin independently predicts coronary artery disease, myocardial infarction, and cardiovascular mortality, even after adjusting for traditional risk factors, obesity, and other metabolic variables.
Anti-inflammatory signal: adiponectin directly suppresses TNF-alpha, IL-6, and other pro-inflammatory cytokines while stimulating IL-10 (anti-inflammatory). Low adiponectin contributes to the chronic low-grade inflammation underlying metabolic syndrome, atherosclerosis, and many autoimmune conditions.
Fatty liver and liver health: adiponectin suppresses hepatic lipogenesis and promotes hepatic fatty acid oxidation. Low adiponectin is strongly associated with non-alcoholic fatty liver disease (NAFLD), and raising adiponectin is a key mechanism through which weight loss and exercise reverse hepatic steatosis.
Cancer risk: adiponectin has anti-proliferative and pro-apoptotic effects in multiple cancer cell lines. Low adiponectin is associated with increased risk of colorectal, breast, endometrial, and prostate cancer, which may partially explain the obesity-cancer connection.

3. Standard Lab Reference Range

Population	Standard Range	Units
Men (adult)	3 to 20	mcg/mL (mg/L)
Women (adult)	5 to 25	mcg/mL (mg/L)

Standard ranges vary considerably by laboratory platform. Women naturally have higher adiponectin levels than men at equivalent body fat percentages due to estrogen's stimulatory effect on adiponectin secretion and the sex-specific distribution of subcutaneous versus visceral fat. Postmenopausal decline in estrogen is accompanied by falling adiponectin, contributing to the increase in metabolic risk after menopause.

4. Optimal Functional Medicine Range

Adiponectin Level	Men Interpretation	Women Interpretation
Above 15 mcg/mL	Excellent: high insulin sensitivity, low metabolic risk	Excellent: high insulin sensitivity, low metabolic risk
10 to 15 mcg/mL (M) / 12 to 15 mcg/mL (W)	Optimal: good metabolic health	Optimal: good metabolic health
7 to 10 mcg/mL (M) / 9 to 12 mcg/mL (W)	Low-normal: early adipose dysfunction; address visceral fat	Low-normal: early adipose dysfunction; lifestyle optimization
Below 7 mcg/mL (M) / Below 9 mcg/mL (W)	Low: significant metabolic dysfunction; comprehensive intervention	Low: significant metabolic dysfunction; comprehensive intervention

5. Symptoms Associated With Low Adiponectin

Low adiponectin is largely a silent finding because it reflects underlying metabolic dysfunction rather than producing direct symptoms. The clinical picture is that of the underlying insulin resistance and metabolic syndrome it enables:

Abdominal weight gain and difficulty losing weight despite dietary effort
Post-meal energy crashes and carbohydrate cravings
Fatigue and reduced energy throughout the day
Elevated fasting triglycerides and low HDL cholesterol
Elevated blood pressure
Brain fog and reduced mental clarity
Non-alcoholic fatty liver disease (found incidentally on imaging)
Elevated fasting insulin or HOMA-IR
Elevated hs-CRP and chronic low-grade inflammatory state
In women: PCOS, irregular cycles, and androgenic symptoms (low adiponectin is strongly associated with PCOS)

6. What Causes Low Adiponectin

Visceral adiposity: the primary driver; visceral fat cells are metabolically active and produce high levels of inflammatory cytokines (TNF-alpha, IL-6) that directly suppress adiponectin secretion from surrounding adipocytes; reducing visceral fat is the most impactful intervention
Insulin resistance: creates a bidirectional suppression loop; insulin resistance itself suppresses adiponectin through inflammatory pathways, and low adiponectin worsens insulin resistance
Chronic inflammation: elevated TNF-alpha and IL-6 directly inhibit adiponectin gene transcription and secretion
Smoking: independently suppresses adiponectin through oxidative and inflammatory pathways
High refined carbohydrate and fructose diet: drives visceral fat accumulation and insulin resistance, the primary mediators of adiponectin suppression
Physical inactivity: exercise is a primary stimulant of adiponectin secretion; sedentary lifestyle reduces adiponectin independent of body weight
Menopause: estrogen stimulates adiponectin production; postmenopausal estrogen decline is accompanied by falling adiponectin levels
Hypothyroidism: low thyroid function is associated with reduced adiponectin levels and impaired adipose tissue metabolism
PCOS: hyperinsulinemia and insulin resistance in PCOS suppress adiponectin; low adiponectin in turn worsens ovarian androgen production

7. How to Improve This Marker

Nutrition

Mediterranean diet pattern: the most evidence-based dietary intervention for raising adiponectin; high in olive oil, fish, vegetables, legumes, and whole grains; reduces visceral fat and inflammatory cytokine burden
Eliminate refined carbohydrates and added fructose: reduces visceral fat accumulation and insulin resistance, the primary suppressors of adiponectin
Increase dietary fiber: viscous fibers reduce post-meal glucose and insulin spikes and support gut microbiome health, which influences adiponectin signaling
Omega-3 fatty acids (EPA and DHA): activate PPAR-alpha and stimulate adiponectin gene expression; 2 to 4g daily consistently raises adiponectin in clinical trials
Avoid trans fats: strongly suppress adiponectin and promote visceral fat deposition
Coffee consumption: surprisingly consistent association with higher adiponectin in epidemiological studies; mechanism may involve chlorogenic acid and other polyphenols

Lifestyle

Aerobic exercise: the most potent natural stimulus for adiponectin secretion; 30 to 60 minutes of moderate-intensity aerobic exercise most days of the week consistently raises adiponectin by 15 to 45% in clinical studies
Weight loss: every kilogram of visceral fat lost is associated with a measurable rise in adiponectin; a 5 to 10% reduction in body weight reliably improves adiponectin by 20 to 40%
Resistance training: adds independent adiponectin-raising effect beyond aerobic exercise through improved insulin sensitivity and reduced visceral fat
Smoking cessation: directly raises adiponectin within weeks
Optimize sleep: poor sleep quality suppresses adiponectin and accelerates visceral fat accumulation; 7 to 9 hours of quality sleep is protective
Stress reduction: chronic cortisol elevation drives visceral fat deposition; addressing the HPA axis indirectly raises adiponectin

Targeted Support

Magnesium (300 to 400mg glycinate or malate daily): magnesium deficiency is strongly associated with low adiponectin; supplementation raises adiponectin in insulin-resistant individuals
Berberine (500mg three times daily): activates AMPK (the same target as metformin); consistently raises adiponectin in clinical trials while improving insulin sensitivity and lipid profiles
Curcumin (500 to 1,000mg as bioavailable formulation daily): anti-inflammatory effects reduce TNF-alpha and IL-6, the primary suppressors of adiponectin secretion
Resveratrol: SIRT1 activator; raises adiponectin in several clinical trials, particularly in combination with caloric restriction
Metformin: pharmaceutical AMPK activator; consistently raises adiponectin in insulin-resistant patients; well-tolerated and evidence-based
GLP-1 receptor agonists (semaglutide, tirzepatide): produce dramatic visceral fat loss; associated with significant adiponectin increases as visceral adiposity resolves

8. Related Lab Tests

Fasting InsulinComplementary Insulin Resistance Marker

→

HOMA-IRQuantifies the Degree of Insulin Resistance

→

TG/HDL RatioLipid Expression of Insulin Resistance

→

hs-CRPInflammatory Mediators Suppress Adiponectin

→

LeptinOpposing Adipokine; Elevated in Obesity

→

HbA1c90-Day Glucose Average; Late Marker

→

9. When Testing Is Recommended

Metabolic syndrome evaluation: adiponectin is one of the earliest biomarkers to fall in developing insulin resistance
Patients with abdominal obesity, elevated triglycerides, or low HDL even with normal fasting glucose
Family history of type 2 diabetes or cardiovascular disease with desire for early risk detection
PCOS evaluation; low adiponectin is strongly associated with the insulin-resistant PCOS phenotype
Baseline and monitoring during weight loss, exercise programs, or metabolic interventions
Non-alcoholic fatty liver disease evaluation
Cardiovascular risk stratification beyond standard lipid panel
Any comprehensive functional medicine metabolic panel

10. Clinical Perspective

Clinical Perspective

Adiponectin is the hormone I think of as the metabolic early warning system. It falls years before glucose rises, it falls before HbA1c becomes abnormal, and it falls even before fasting insulin in some patients. When I see a man in his early 40s with a waistline expanding despite reasonable eating habits, normal fasting glucose of 91, and a fasting insulin of 9, his adiponectin is often already below 6 or 7 mcg/mL. The adipose tissue is already dysfunctional. The insulin resistance is already building. We have a 10-year window to intervene before this becomes type 2 diabetes, but only if we are measuring the right things. Adiponectin tells us the window is open and getting smaller. That is worth knowing, and worth acting on.

Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma

11. Frequently Asked Questions

What is adiponectin?

Adiponectin is an anti-inflammatory hormone secreted exclusively by fat cells (adipocytes). Unlike most adipokines, adiponectin has beneficial metabolic effects: it enhances insulin sensitivity, reduces hepatic glucose production, promotes fatty acid oxidation in muscle, and suppresses inflammatory cytokine production. Paradoxically, the more visceral fat a person accumulates, the less adiponectin their fat cells produce, making low adiponectin a reliable marker of metabolic dysfunction.

What is the optimal adiponectin level?

In functional medicine, optimal adiponectin is above 10 mcg/mL for men and above 12 mcg/mL for women. Women naturally have higher levels than men due to estrogen's stimulatory effects. Values below 7 mcg/mL in men and below 9 mcg/mL in women are associated with significant insulin resistance and elevated cardiovascular risk, even when fasting glucose and HbA1c appear normal.

What does low adiponectin mean?

Low adiponectin indicates adipose tissue dysfunction and is strongly associated with insulin resistance, metabolic syndrome, visceral adiposity, elevated triglycerides, low HDL, elevated inflammatory markers, and increased cardiovascular and type 2 diabetes risk. It is one of the earliest detectable markers of metabolic deterioration, often falling before fasting glucose, HbA1c, or even fasting insulin becomes significantly abnormal.

How do you increase adiponectin naturally?

The most effective interventions are aerobic exercise (30 to 60 minutes most days, which raises adiponectin by 15 to 45% in clinical studies), weight loss particularly targeting visceral fat (every kilogram of visceral fat lost raises adiponectin measurably), Mediterranean diet pattern, omega-3 fatty acids (2 to 4g daily of EPA and DHA), magnesium supplementation, and berberine. Eliminating refined carbohydrates and fructose reduces visceral fat accumulation, the primary suppressor of adiponectin production.

What is the relationship between adiponectin and PCOS?

Low adiponectin is strongly associated with the insulin-resistant phenotype of PCOS. Insulin resistance lowers adiponectin through inflammatory pathways, and low adiponectin in turn worsens insulin resistance and ovarian androgen overproduction. Raising adiponectin through weight loss, exercise, metformin, and inositol is an important component of PCOS management that addresses the underlying metabolic driver rather than just the hormonal symptoms.

Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.

Adiponectin falls before glucose rises. It is the earliest metabolic warning we have.

A complete metabolic panel measures what your annual labs miss. Schedule a consultation for comprehensive metabolic evaluation including adiponectin, fasting insulin, and TG/HDL ratio.

Schedule a Consultation

Medical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.